Related Experiment Video
Updated: Jun 26, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
10-Year Change in the Laboratory-Based Prevalence of Chronic Kidney Disease in Patients from a Brazilian Cardiologic
Farid Samaan1,2, Rubens Carvalho Silveira3, Kleber Gomes Franchini1
1Dante Pazzanese Institute of Cardiology, São Paulo 04012-909, SP, Brazil.
Insights
Chronic kidney disease (CKD) prevalence in Brazilian cardiology patients rose significantly over a decade. This highlights an urgent need for healthcare systems to manage increasing CKD complexity and risk of kidney failure.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Assessing chronic kidney disease (CKD) prevalence trends in a Brazilian cardiology patient cohort.
- Evaluating longitudinal data from 2014-2023 on serum creatinine and urine albumin-creatinine ratio (UACR).
Purpose of the Study:
- To estimate the variation in CKD prevalence.
- To assess CKD risk stratification using estimated glomerular filtration rate (eGFR) and UACR.
Main Methods:
- Analysis of outpatient serum creatinine and UACR from adult patients (≥18 years).
- CKD defined by eGFR < 60 mL/min/1.73 m².
- Risk stratification using a CKD heatmap combining eGFR and UACR.
Main Results:
- Age- and sex-adjusted CKD prevalence increased from 20% to 31% (R² = 0.853, p < 0.001).
- High/very high CKD risk group prevalence rose from 14% to 21% (R² = 0.945, p < 0.001).
- Cumulative CKD incidence was 21.7%, higher in females and older adults.
Conclusions:
- A nearly 50% rise in laboratory-diagnosed CKD over 10 years was observed.
- Healthcare services must adapt to manage a growing CKD population with increased risk for kidney replacement therapy.
Abstract:
Background: We aim to estimate the variation in the prevalence of chronic kidney disease (CKD) in patients from a Brazilian cardiologic center. Methods: The outpatient serum creatinine level and urine albumin-creatinine ratio (UACR) in samples from patients ≥18 years old between 2014 and 2023 were evaluated. CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2. Participants were categorized into low-, moderate-, high- or very high-risk groups according to the CKD heatmap, which combines eGFR with UACR results. Results: The mean number of adults with serum creatinine results per year was 36,477 ± 7239, and the mean number of those with UACR results was 16,870 ± 4310. The age- and sex-adjusted prevalence of participants with CKD increased significantly (from 20% to 31%; R2 = 0.853; p < 0.001), as was the prevalence of individuals in the high or very high CKD risk groups (14% to 21%; R2 = 0.945; p < 0.001). The cumulative incidence of CKD during the study period was 21.7% and was higher in females and in older age groups. Conclusions: The roughly 50% increase in the laboratory-based CKD prevalence over 10 years underscores the need for healthcare services to adapt to managing a population with growing complexity and a heightened risk of requiring kidney replacement therapy.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance